SNDX SYNDAX PHARMACEUTICALS INC Earnings Reports 8-K Filing 2023 - Other Events Syndax Pharmaceuticals announced topline data from the AUGMENT-101 trial of revumenib in patients with relapsed/refractory leukemia.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC